CONSENSUS B Tat-23 is a conserved Tat fragment studied for its role in protein-protein interaction networks involved in transactivation. Its sequence facilitates mapping essential regulatory motifs. Researchers evaluate its conformation to understand structural control of transcriptional complexes. The peptide supports comparative analyses of conserved Tat domains.
CAT No: H09280
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.